Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 2-Chlorodeoxyadenosine inhibits activity of adenosine deaminase and S-adenosylhomocysteine hydrolase in patients with chronic lymphocytic leukaemia.

Literature DB >> 9071923

2-Chlorodeoxyadenosine inhibits activity of adenosine deaminase and S-adenosylhomocysteine hydrolase in patients with chronic lymphocytic leukaemia.

K Warzocha, K Fabianowska-Majewska, J Bloński, E Krykowski, T Robak.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 1997 PMID： 9071923 DOI： 10.1016/s0959-8049(96)00347-4

Source DB: PubMed Journal: Eur J Cancer ISSN： 0959-8049 Impact factor: 9.162

Keyword Cloud
Cited

× No keyword cloud information.

5 in total

1. Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulators.

Authors: Benigno C Valdez; Yang Li; David Murray; Jie Ji; Yan Liu; Uday Popat; Richard E Champlin; Borje S Andersson
Journal: Exp Hematol Date: 2015-02-19 Impact factor: 3.084

2. IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen.

Authors: Marta Libura; Emilia Bialopiotrowicz; Sebastian Giebel; Agnieszka Wierzbowska; Gail J Roboz; Beata Piatkowska-Jakubas; Marta Pawelczyk; Patryk Gorniak; Katarzyna Borg; Magdalena Wojtas; Izabella Florek; Karolina Matiakowska; Bozena Jazwiec; Iwona Solarska; Monika Noyszewska-Kania; Karolina Piechna; Magdalena Zawada; Sylwia Czekalska; Zoriana Salamanczuk; Karolina Karabin; Katarzyna Wasilewska; Monika Paluszewska; Elzbieta Urbanowska; Justyna Gajkowska-Kulik; Grazyna Semenczuk; Justyna Rybka; Tomasz Wrobel; Anna Ejduk; Dariusz Kata; Sebastian Grosicki; Tadeusz Robak; Agnieszka Pluta; Agata Kominek; Katarzyna Piwocka; Karolina Pyziak; Agnieszka Sroka-Porada; Anna Wrobel; Agnieszka Przybylowicz; Marzena Wojtaszewska; Krzysztof Lewandowski; Lidia Gil; Agnieszka Piekarska; Wanda Knopinska; Lukasz Bolkun; Krzysztof Warzocha; Kazimierz Kuliczkowski; Tomasz Sacha; Grzegorz Basak; Wieslaw Wiktor Jedrzejczak; Jerzy Holowiecki; Przemysław Juszczynski; Olga Haus
Journal: Sci Rep Date: 2021-05-11 Impact factor: 4.996

2-Chlorodeoxyadenosine inhibits activity of adenosine deaminase and S-adenosylhomocysteine hydrolase in patients with chronic lymphocytic leukaemia.

1. Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulators.

2. IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen.

Review 3. Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies.

4. Efficient Biocatalytic Synthesis of Dihalogenated Purine Nucleoside Analogues Applying Thermodynamic Calculations.

Review 5. Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases.